Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Boston Life Sciences' O-1369 shows promise for PD

Nov. 9, 2000

Questcor receives continued funding for program in neuroprotection

Nov. 9, 2000

Neurogen discovers new series of compounds interacting with NK3 and/or GABA-A receptors

Nov. 8, 2000

New three-in-one approach to Parkinson's disease

Nov. 8, 2000

Permax approved in Canada as monotherapy for PD

Nov. 8, 2000

New Gruenenthal compounds bind with high affinity to sodium and calcium channels

Nov. 7, 2000

Synthesis and biological activity of 5-ht6 receptor antagonists reported by Canadian company

Nov. 7, 2000

New 5-HT7 receptor antagonists designed at SB

Nov. 7, 2000

CPMP recommends approval of Neurobloc for treatment of cervical dystonia

Nov. 7, 2000

SynGenix and Glaxo Wellcome collaborate on novel pain therapies

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...